266 related articles for article (PubMed ID: 31352655)
1. Antiplatelet Therapy in Cerebral Small Vessel Disease.
Bouasquevisque DS; Benavente OR; Shoamanesh A
Curr Neurol Neurosci Rep; 2019 Jul; 19(9):61. PubMed ID: 31352655
[TBL] [Abstract][Full Text] [Related]
2. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
Al-Shahi Salman R; Minks DP; Mitra D; Rodrigues MA; Bhatnagar P; du Plessis JC; Joshi Y; Dennis MS; Murray GD; Newby DE; Sandercock PAG; Sprigg N; Stephen J; Sudlow CLM; Werring DJ; Whiteley WN; Wardlaw JM; White PM;
Lancet Neurol; 2019 Jul; 18(7):643-652. PubMed ID: 31129065
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials.
Kwok CS; Shoamanesh A; Copley HC; Myint PK; Loke YK; Benavente OR
Stroke; 2015 Apr; 46(4):1014-23. PubMed ID: 25721018
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
[TBL] [Abstract][Full Text] [Related]
6. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
[TBL] [Abstract][Full Text] [Related]
7. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
Davis KA; Miyares MA; Dietrich E
Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
[TBL] [Abstract][Full Text] [Related]
8. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
Gouya G; Arrich J; Wolzt M; Huber K; Verheugt FW; Gurbel PA; Pirker-Kees A; Siller-Matula JM
Stroke; 2014 Feb; 45(2):492-503. PubMed ID: 24368560
[TBL] [Abstract][Full Text] [Related]
10. Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.
Shoamanesh A; Pearce LA; Bazan C; Catanese L; McClure LA; Sharma M; Marti-Fabregas J; Anderson DC; Kase CS; Hart RG; Benavente OR;
Ann Neurol; 2017 Aug; 82(2):196-207. PubMed ID: 28681535
[TBL] [Abstract][Full Text] [Related]
11. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet therapy as a risk factor for microbleeds in intracerebral hemorrhage patients: analysis using specific antiplatelet agents.
Naka H; Nomura E; Kitamura J; Imamura E; Wakabayashi S; Matsumoto M
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):834-40. PubMed ID: 22784819
[TBL] [Abstract][Full Text] [Related]
13. Update on Dual Antiplatelet Therapy for Secondary Stroke Prevention.
Stringberg A; Camden R; Qualls K; Naqvi SH
Mo Med; 2019; 116(4):303-307. PubMed ID: 31527979
[TBL] [Abstract][Full Text] [Related]
14. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
[TBL] [Abstract][Full Text] [Related]
15. Post-stroke treatment with K-134, a phosphodiesterase 3 inhibitor, improves stroke outcomes in the stroke-prone spontaneously hypertensive rat model-A comparative evaluation of antiplatelet drugs.
Yoshida H; Itoh S; Ferdousi F; Isoda H
J Pharmacol Sci; 2022 Feb; 148(2):229-237. PubMed ID: 35063138
[TBL] [Abstract][Full Text] [Related]
16. [Antiplatelet therapy: update in secondary stroke prevention].
Uchiyama S
Brain Nerve; 2013 Jul; 65(7):771-82. PubMed ID: 23832980
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis.
Ding L; Peng B
Eur J Neurol; 2018 Oct; 25(10):1276-1284. PubMed ID: 29855121
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis.
McHutchison C; Blair GW; Appleton JP; Chappell FM; Doubal F; Bath PM; Wardlaw JM
Stroke; 2020 Aug; 51(8):2374-2385. PubMed ID: 32646330
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.
Pearce LA; McClure LA; Anderson DC; Jacova C; Sharma M; Hart RG; Benavente OR;
Lancet Neurol; 2014 Dec; 13(12):1177-85. PubMed ID: 25453457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
